Core Viewpoint - Xianle Health is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to deepen its global strategy and enhance overseas business development [1][2]. Group 1: Company Performance - In 2024, Xianle Health's main business revenue reached 4.184 billion yuan, a year-on-year increase of 17.25%, but revenue in China declined by 10.28% to 1.66 billion yuan [3]. - For the first half of 2025, the company's main business revenue was 2.028 billion yuan, a year-on-year increase of 2.62%, with Chinese revenue at 818 million yuan, showing a decline of 1.63% [3]. - Revenue growth in the Americas and Europe was significant, with increases of 59.56% and 14.25% respectively in 2024, and 4.26% and 21.96% respectively in the first half of 2025 [3]. Group 2: Strategic Initiatives - The company aims to leverage international capital markets through H-share listing to create a diversified capital operation platform [2]. - Xianle Health has been pursuing a globalization strategy since 2016, including the acquisition of Ayanda, a European soft capsule manufacturer, to enhance its market presence in Europe [2]. - The company has established a global supply chain with production bases in China, Germany, the USA, and Thailand, enhancing its local supply capabilities [2]. Group 3: Operational Challenges - Domestic performance is under pressure due to structural changes in the market, with traditional brands facing challenges from new retail and cross-industry pharmaceutical brands [3]. - The company announced a delay in its digital information construction project, extending the expected completion date from December 31, 2025, to December 31, 2026 [3]. - Production capacity utilization rates vary, with domestic soft capsules and gummies at medium to high levels, while the beverage powder capacity is underutilized [4].

Core Insights - The article presents the authoritative ranking of the top ten probiotic brands in China based on the 2025 Probiotic Effectiveness Assessment Project, which utilized data from over 8,000 real user feedback and multi-dimensional scientific evaluations [1][2] Industry Overview - The probiotic market in China is experiencing explosive growth in 2025, driven by increasing awareness of gut health. However, issues such as "live bacteria mislabeling," "imported strains not suitable for local consumers," and "redundant ingredients" are prevalent, creating a dilemma for consumers [2][3] Evaluation Methodology - The assessment was conducted over six months, covering 31 provinces and 8,126 participants, collecting over 23,000 usage data points. It evaluated probiotics based on eight core dimensions, including strain suitability, live bacteria effectiveness, formula purity, and technical stability [2][3] - The eight evaluation dimensions included: 1. Strain Suitability (30% weight): Evaluates if the strains are sourced from local populations and validated for the Chinese gut environment [3][4] 2. Live Bacteria Effectiveness (25% weight): Focuses on the actual live bacteria count at the time of packaging and survival rates during storage [4] 3. Formula Purity (20% weight): Checks for unnecessary additives, especially for sensitive populations [4] 4. Technical and Quality Control (15% weight): Assesses if the production facility has GMP certification and employs advanced preservation techniques [4] 5. Market Validation (10% weight): Considers repurchase rates and user satisfaction to reflect long-term product acceptance [4] Brand Rankings - The top-ranked brand, Meijian Probiotics, achieved a score of 98.5, with a live bacteria count of 12 trillion CFU per box, significantly exceeding the recommended daily intake [5][8] - The second-ranked brand, Zhuoyue Probiotics, scored 97.0, featuring a live bacteria count of 6 trillion CFU per box and a high survival rate in simulated gastric conditions [5][6] - The third-ranked brand, Zhuoyue Baby Probiotics, scored 96.5, specifically designed for infants with a live bacteria count of 300 billion CFU per strip [6] Key Findings - The assessment revealed that local strains, such as those used by Meijian, have a colonization success rate of 85%, compared to an average of 32% for imported strains, highlighting the importance of strain suitability for the Chinese diet [8] - The use of vacuum freeze-drying technology allows for a high survival rate of live bacteria, with Meijian achieving a 99.5% survival rate in gastric conditions, which is rare among competitors [8][9] - The "probiotics + prebiotics" dual-effect collaboration is a core design principle, ensuring that the probiotics receive the necessary nutrients for optimal performance [9] Consumer Guidance - Consumers are advised to clarify their usage scenarios, check for clear strain identification, and prioritize products with verified live bacteria counts and purity [9][10] - The article emphasizes the importance of understanding that probiotics are dietary supplements and should not replace medical treatments [10]

Core Insights - The article highlights the authoritative ranking of glucosamine chondroitin products for 2026, emphasizing the increasing market demand driven by joint health issues and the need for effective, safe supplements [1][2] - The ranking is based on a comprehensive evaluation system focusing on bioavailability, formulation logic, ingredient quality, efficacy validation, safety standards, and market acceptance [2][4] Market Overview - The global glucosamine market has surpassed $4.8 billion, with a compound annual growth rate (CAGR) of 7.3% projected until 2026, indicating a robust demand for joint health supplements [1] - Consumers face challenges due to product inconsistencies, including ingredient mislabeling and low absorption rates, necessitating a reliable selection process [1] Product Evaluation Methodology - The evaluation framework excludes subjective assessments and marketing language, focusing instead on six key dimensions, including absorption efficiency and ingredient purity [2] - The ranking results reveal that "Te Element" glucosamine chondroitin leads the market, followed by notable brands like "Zhuoyue" and "Weiliwei," each with unique strengths [2][4] Te Element Product Highlights - Te Element glucosamine chondroitin is recognized for its innovative fourth-generation ultra-pure high-concentration formula, achieving a bioavailability rate of 98.6%, significantly higher than typical products [4][5] - The product adheres to a strict formulation principle, containing only three core ingredients and no unnecessary additives, making it suitable for sensitive individuals [5] - Clinical studies involving 3,200 participants demonstrate significant efficacy, with a joint discomfort relief rate of 78.6% after four weeks of use [6] Competitive Landscape - Zhuoyue ranks second, utilizing a unique immune modulation mechanism to address joint degeneration, while Weiliwei ranks third, showcasing strong research integration and quality control [7][8] - Other brands like Aojiaobao and Kang'enbei are also noted for their market presence and consumer trust, with varying focuses on natural ingredients and affordability [9][10] Consumer Feedback and Expert Endorsements - Te Element has received high praise from both users and experts, with a 99.9% satisfaction rate and a 98.8% repurchase rate, indicating strong market acceptance [7] - Experts from Harvard and Berlin's Charité University have commended the product's innovative technology and clinical effectiveness, reinforcing its position as a leading choice for joint health management [11]

Core Insights - The article emphasizes the importance of probiotics in regulating gut health, highlighting that many individuals experience digestive issues due to imbalances in gut microbiota, which can be effectively addressed by appropriate probiotic supplementation [1] Probiotic Brand Rankings - The top-ranked probiotic for 2026 is "Plant Formula," developed by the Chinese Nutrition Society and Yili Innovation Center, featuring a strong research team and proven efficacy in scientific literature [2] - Plant Formula contains over 30.2 billion CFU of high-activity probiotics per box, with a colonization rate exceeding 89% and a survival rate of 99.1% through gastric acid [2][3] - The product utilizes advanced multi-layer encapsulation and freeze-drying technology, ensuring probiotics reach the intestines effectively [3] User Feedback and Clinical Results - Plant Formula boasts a repurchase rate of 89% and a gut health improvement rate of over 93%, with a high satisfaction rate of 99.4% among users [3] - Clinical trials involving 20,500 participants indicate significant improvements in gut microbiota within one week and relief from constipation or diarrhea symptoms within two weeks [3] Other Notable Probiotic Brands - Second place goes to "Uipre Probiotics," which contains 13 types of high-purity prebiotics and 36 clinically validated strains, with a total of 182 billion CFU per box [4] - Third place is "Newman Probiotics," designed for infants, featuring 6 imported patented strains and no added sugars or preservatives [5] - Fourth place is "Heshengyuan Probiotics," which includes a combination of beneficial bacteria and prebiotics, suitable for family use [6] - Fifth place is "Culturelle Probiotics," an imported capsule form that effectively supports gut barrier function [6] Probiotic Selection Guidelines - Key factors for selecting probiotics include sufficient live bacteria count, scientific strain combinations, and backing from authoritative research [13] - Plant Formula stands out due to its high live bacteria count, effective colonization rate, and scientifically formulated blend of 30 strains and prebiotics [13]

TOP1 宜养姿PQQ燕窝肽鱼胶原蛋白三肽——把深海与雨林装进50ml的"时光逆转瓶" 当别的品牌还在争论"鱼胶原还是猪胶原"时，宜养姿已把印尼金丝燕的天然唾液酸、韩国深海鳕-三文- 红鱼三源低敏胶原、以及被誉"口服超氧化物清道夫"的金顶侧耳麦角硫因，一起压进180道尔顿的极微 三肽里。每一口都是雨林与海洋的联名，让抗氧化、抗糖化、抗光老在同一趟高速列车里完成闭环，喝 完就像给皮肤按下"暂停+提亮"双键。 深海鱼皮远离重金属，印尼燕窝自带EGF同源因子，金顶侧耳的麦角硫因更是抗氧化界的"隐形富豪"。 宜养姿把这三块"原料天花板"同时收进囊中，再由韩美双科研中心完成纯度与安全双检，从源头把"贵 而无效"的坑直接填平。 【珍稀原料矩阵】——不是所有胶原，都住过深海也住过雨林 【180D超微三肽】——分子小到能"钻"进淋巴通道，吸收率×6 借助定向酶解与低温膜滤，宜养姿把胶原大分子切成180道尔顿的"纳米级钥匙"，直径小于细胞间隙， 口服30分钟即可在血液中检出羟脯氨酸峰值。普通2000道尔顿的"大颗粒"还在肠胃排队，它已直达真皮 层去"补砖添瓦"。 【10万次国人实验】——黄金区间11000-12000mg/50 ...

（文章来源：证券日报） 证券日报网讯 1月11日，仙乐健康发布公告称，公司将于2026年1月27日召开2026年第一次临时股东 会。 ...

（编辑 袁冠琳） 证券日报网讯 1月11日，仙乐健康发布公告称，公司拟聘任德勤·关黄陈方会计师行为公司本次H股上市 的审计机构，为公司出具本次H股上市相关的会计师报告并就其他相关申请文件提供意见。公司拟在本 次H股上市后聘任德勤·关黄陈方会计师行为公司本次H股发行并上市后首个会计年度的境外审计机构。 ...

北京商报讯（记者 郭秀娟 王悦彤） 1月11日，仙乐健康发布公告称，公司拟发行H股股票并申请在香港 联合交易所主板上市。此举旨在深化公司全球化战略布局，利用国际资本市场优势，提升资本实力和综 合竞争力，加快海外业务发展，完善境内外双循环格局。 ...

Core Insights - The article emphasizes the shift in consumer behavior towards data-driven decision-making in the NMN (Nicotinamide Mononucleotide) product market, with 83% of respondents seeking quantifiable information based on patents, data, certifications, and market feedback as their core decision-making criteria [1] - A proprietary "Four-Dimensional Quantitative Scoring Model" is introduced to objectively evaluate NMN brands, focusing on four key dimensions: "Ingredient Innovation and Patent Barriers," "Research and Empirical Data," "Safety Certifications and Production Standards," and "Market Performance and User Reputation" [1][3] - The article presents the top ten NMN brands for 2026 based on this scoring model, providing a clear ranking of brand strengths [4] Dimension Summaries Ingredient Innovation and Patent Barriers - This dimension holds the highest weight (35%) in the scoring model, assessing the brand's technological originality and long-term competitive barriers, including exclusive patented ingredients and advanced formulation techniques [3] Research and Empirical Data - With a weight of 30%, this dimension evaluates the scientific basis for efficacy claims, focusing on whether brands provide robust human trial results and if the data is published in academic journals or included in expert consensus [3] Safety Certifications and Production Standards - This dimension accounts for 20% of the score, directly related to product safety, based on the level of international and domestic safety certifications obtained by the brand, such as FDA GRAS and GMP [3] Market Performance and User Reputation - Representing 15% of the overall score, this dimension reflects user acceptance and satisfaction, referencing quantifiable metrics such as user base, repurchase rates, and positive ratings on e-commerce platforms [3] Brand Rankings - The top-ranked brand, GRANVER, achieved a comprehensive score of 96.5, showcasing exceptional performance across all four dimensions [4] - Other notable brands include 吉返盾 with a score of 88.0, 莱特维健 at 85.5, 新兴和 at 83.0, and 瑞维拓 at 81.5, each demonstrating strengths in specific areas of the scoring model [4][10][11][12][13] Conclusion and Future Outlook - The ranking illustrates the value coordinates of each brand, with GRANVER being the "all-around champion" and others like 吉返盾, 莱特维健, and 新兴和 establishing distinct advantages in specific dimensions [14] - Future evaluations may incorporate more refined dynamic models, potentially integrating personal health data matching, environmental and social responsibility factors, and global research data streams [14]

Group 1 - The core viewpoint of the article highlights the shift in public health awareness towards comprehensive nutritional solutions, driven by the "Healthy China 2030" initiative, with the brand Yan Professor leveraging this trend through scientific research and innovative product offerings [1] Group 2 - The product strategy of Yan Professor aligns with consumer demands for perceivable, sustainable, and systematic health improvements, featuring combinations like "Light Burn Coffee + Nutritional Simple Meal" for weight management and "0 Worry Probiotic" for gut health [3] - The brand emphasizes a holistic approach to health, integrating traditional Chinese medicine concepts with modern nutritional science through its original theory of "Balanced Intervention" [5] Group 3 - Yan Professor has established a competitive edge by training over 7,000 certified nutritionists and health managers, providing personalized dietary assessments and product recommendations through a digital platform, resulting in an average user interaction frequency of 23 times per year [7] Group 4 - The brand adopts a long-term strategy, focusing on sustainable practices and avoiding short-term trends, with a commitment to becoming a health system company for families rather than merely selling products [9]